Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Öhman, historically referred to as Öhman Fondkommission, is a Swedish financial services and investment group rather than a life science, biotech, pharma, or healthcare company. The group traces its roots to 1906 and is family-owned, with activities spanning asset management, investing, and ownership of financial businesses. Publicly available information indicates that the current legal entity at the group level is E. Öhman J:or Aktiebolag, based in Stockholm, Sweden. Öhman appears to operate as an active investment and holding organization with interests including fund management and ownership stakes in Nordic financial businesses such as Nordnet and Lannebo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Öhman Fondkommission.